Transpharma-Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries Limited

Published: Jun 11, 2007

LOD, ISRAEL, June 11, 2007 - TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today it has received its second milestone payment from Teva Pharmaceutical Industries for the successful development of a stable human growth hormone (hGH) dry form patch required for advanced clinical trials of Teva’s transdermal hGH product.

Back to news